They contain pioglitazone and are used in adults with type 2 diabetes when improved insulin sensitivity is needed. Pioglitazone helps body tissues respond more effectively to insulin, supporting…
They contain pioglitazone and are used in adults with type 2 diabetes when improved insulin sensitivity is needed. Pioglitazone helps body tissues respond more effectively to insulin, supporting lower blood glucose levels alongside diet and physical activity. [1]
Actos is an oral thiazolidinedione treatment for type 2 diabetes mellitus. Its active ingredient, pioglitazone, is used when the body still produces insulin but does not use it efficiently, a problem known as insulin resistance.
It does not replace insulin in type 1 diabetes. It is also not intended for diabetic ketoacidosis, which requires urgent medical treatment.
Pioglitazone belongs to the thiazolidinedione class. It works gradually, so it is not a tablet that produces an immediate change in blood glucose after a single dose.
The medicine can be prescribed alone or alongside other glucose-lowering treatments. The dose is decided individually, taking age, other medicines and health conditions into account.
Actos contains pioglitazone as its active ingredient. Pioglitazone is an oral thiazolidinedione treatment that helps body tissues respond more effectively to insulin. The exact tablet strength is not specified here.
Actos is used in adults with type 2 diabetes mellitus when the body still produces insulin but does not use it efficiently because of insulin resistance. It supports blood glucose control alongside diet and physical activity and is not used to replace insulin in type 1 diabetes.
Actos tablets should be swallowed whole with water. They may be taken with food or on an empty stomach. The prescribing clinician selects the starting dose and decides whether it should be adjusted after reviewing blood glucose results, tolerability, weight changes and signs of fluid retention.
A practical daily routine includes:
Avoid or review Actos carefully in these situations:
Actos is not for you if you have heart failure or a history of heart failure. It is also unsuitable for people with active bladder cancer, a previous history of bladder cancer, or unexplained visible blood in the urine.
Weight gain, oedema and upper respiratory tract infections are among the commonly reported effects of pioglitazone. Some people notice ankle swelling first, often late in the day when socks leave deeper marks. Others notice that rings, shoes or trousers feel tighter over a short period.
Low blood glucose is uncommon with Actos alone because pioglitazone does not directly stimulate insulin secretion. Its likelihood rises when insulin or a sulfonylurea is also used.
More serious concerns include heart failure caused or worsened by fluid retention, bone fractures, visual disturbance from macular oedema, and a small increased bladder-cancer risk identified with prolonged exposure in some studies. The European Medicines Agency strengthened contraindications and warnings for pioglitazone in 2011 after reviewing this safety signal. [3]
Pioglitazone activates peroxisome proliferator-activated receptor gamma, usually shortened to PPAR-γ. This nuclear receptor influences genes involved in glucose and lipid metabolism. When PPAR-γ is activated, fat and muscle cells become more responsive to insulin, allowing glucose to move from the blood into cells more efficiently.
The liver also becomes less likely to release excess glucose into the bloodstream. These effects can reduce insulin resistance without directly forcing the pancreas to release insulin.
This mechanism explains an important trade-off. Pioglitazone has a low intrinsic risk of hypoglycaemia when used on its own, yet it can contribute to low blood sugar when combined with insulin or a sulfonylurea. Weight gain and fluid retention can also occur because PPAR-γ activity affects fat storage and kidney sodium handling. [2]
One frequent mistake is expecting Actos to behave like a fast-acting glucose treatment. It works through gene-regulated changes in tissue insulin response, so benefit is assessed over weeks through glucose patterns and HbA1c rather than hour by hour.
Another error is ignoring gradual fluid retention. Swollen ankles after a long day can have many causes, yet new swelling after starting or increasing pioglitazone deserves prompt clinical assessment.
People also sometimes stop treatment abruptly after seeing a few better readings. Type 2 diabetes remains present even when readings improve, and sudden discontinuation may allow glucose to rise again.
Treatment choice in type 2 diabetes depends on HbA1c, body weight, kidney function, cardiovascular history, heart-failure risk, other medicines and personal treatment goals. Actos is one insulin-sensitising option, not a universal first choice.
| Treatment approach | Main action | Key limitation |
|---|---|---|
| Pioglitazone | Improves insulin sensitivity through PPAR-γ | Can cause weight gain and fluid retention |
| Metformin | Reduces liver glucose production | May cause gastrointestinal effects |
| Insulin secretagogues | Increase pancreatic insulin release | Higher hypoglycaemia risk |
| Insulin | Replaces or supplements insulin | Requires injection and can cause hypoglycaemia |
Pioglitazone may suit someone whose main metabolic problem is insulin resistance and who cannot reach their glucose target with lifestyle measures and other oral treatment alone. It is less suitable where fluid retention, established heart failure or a history of bladder cancer changes the risk balance.
In clinical practice, prescribers tend to judge Actos by trends rather than a single glucose reading. HbA1c, body weight, blood-pressure control, ankle swelling and symptoms of breathlessness all matter because the medicine changes insulin sensitivity over time.
Doctors often see the best outcomes when tablets are combined with realistic food habits and regular movement. Skipping meals to compensate for a high reading is rarely helpful, especially when insulin or a sulfonylurea is part of the regimen.
Actos does not usually require a taper because pioglitazone does not cause physical dependence. Blood glucose can rise again after stopping because the insulin-sensitising effect fades, so the treatment plan should be changed deliberately rather than abandoned. The FDA prescribing information from 2016 describes pioglitazone as a glucose-lowering therapy requiring ongoing assessment of response and tolerability. [1] A prescriber may replace it, adjust another diabetes medicine or arrange earlier glucose testing.
Alcohol can make glucose control less predictable, especially when meals are skipped or when insulin or a sulfonylurea is also used. Heavy alcohol intake may increase the chance of hypoglycaemia and can worsen liver-related concerns. WHO guidance updated in 2023 continues to identify alcohol reduction as relevant to non-communicable disease prevention. Keep intake modest, avoid drinking on an empty stomach, and seek urgent help for confusion, sweating or loss of consciousness.
Regular meals with fibre-rich carbohydrate sources, vegetables, protein and unsaturated fats support steadier glucose patterns. Brisk walking, cycling, swimming or resistance work improves insulin sensitivity, complementing the action of pioglitazone. The American Diabetes Association Standards of Care published in 2025 support structured physical activity and nutrition planning as core parts of type 2 diabetes management. Smoking and frequent heavy drinking work against cardiovascular and metabolic goals.
Take the missed tablet when remembered on the same day, unless the next scheduled dose is near. In that case, skip the missed tablet and return to the usual daily routine. Never take two doses together to compensate. The HPRA's 2024 guidance advises that medicine dosing decisions should account for individual treatment plans and concurrent medicines, so repeated missed doses should be raised at the next review. A pharmacist can help identify a safe routine if missed doses become frequent.
Do not increase the dose independently. Check whether tablets have been taken consistently, whether any new medicine could be interacting, and whether illness, steroid treatment, reduced activity or dietary changes have affected glucose levels. NICE guidance updated in 2022 recommends treatment intensification based on HbA1c, cardiovascular risk and individual circumstances. A clinician may adjust Actos, add another approach or select a different glucose-lowering medicine.
Actos can be prescribed with insulin, though this combination needs close supervision because it increases the chance of fluid retention and may precipitate or worsen heart failure. New swelling, rapid weight gain or breathlessness should be reported without delay. EMA safety advice from 2011 identifies cardiac monitoring as a key precaution with pioglitazone, especially where insulin is also used. The insulin dose may need adjustment if low blood glucose occurs.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used Actos with metformin for four months after my HbA1c stayed above target. My morning readings came down gradually rather than overnight. I gained some weight, so my diabetes nurse focused on walking after dinner and checking my meals.
Four months 2 Nov 2026I had taken the prescribed daily tablet for nearly three months and found it easy to fit into breakfast. My glucose readings improved, but my ankles looked puffy by the end of the day. The prescriber changed my treatment after reviewing the swelling.
Nearly three months 29 Oct 2026I expected an immediate difference and felt disappointed in the first few weeks. By my next diabetes review, the blood tests were better. Taking it at the same time as brushing my teeth stopped me forgetting it.
7 Oct 2026Actos was added to my existing diabetes tablets for six months. I did not have low blood sugars, but I needed to pay more attention to my weight. Smaller portions and cycling twice a week made that easier.
Six months 23 Oct 2026I stopped taking the tablets for several days when I travelled and my readings crept up again. The daily routine mattered more than I had realised. I now keep a written medicines list in my wallet.
Several days 12 Oct 2026
